The Efficacy and Safety of Irinotecan Plus Temozolomide and Vincristine in Neuroblastoma with Brain Recurrence: A Retrospective Study

被引：0
|
作者：
Wang, J. [1 ]
Zhen, Z. [2 ]
Zhu, S. [3 ]
Lian, Z. [4 ]
Lu, S. [2 ]
Sun, F. [2 ]
Huang, J. [2 ]
Zhang, Y. [5 ]
Sun, X. [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Pediat Oncol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Dept Pediat Oncol, Guangzhou, Peoples R China
[3] Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Childrens Hosp, Med Oncol Dept, Beijing, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Pediat Oncol, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Ctr Canc, Dept Pediat Oncol, Guangzhou, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV0126
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of carboplatin plus paclitaxel in gynecological carcinosarcoma: a Brazilian retrospective study
    da Silva, Jesse L.
    Albuquerque, Lucas Z. de
    Gasparotto, Ana L.
    de Aguiar, Beatriz R. L.
    Rodrigues, Darlyane de S. B.
    Farias, Ticiane C.
    Paulino, Eduardo
    de Melo, Andreia C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (03) : 512 - 520
  • [32] Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study
    Bagatell, Rochelle
    London, Wendy B.
    Wagner, Lars M.
    Voss, Stephan D.
    Stewart, Clinton F.
    Maris, John M.
    Kretschmar, Cynthia
    Cohn, Susan L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 208 - 213
  • [33] Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer
    M. Degirmenci
    B. Karaca
    G. Gorumlu
    R. Durusoy
    G. Demir Piskin
    M. T. Bozkurt
    Y. Cirak
    D. Tunali
    B. Karabulut
    U. A. Sanli
    R. Uslu
    Medical Oncology, 2010, 27 : 585 - 591
  • [34] Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer
    Degirmenci, M.
    Karaca, B.
    Gorumlu, G.
    Durusoy, R.
    Piskin, G. Demir
    Bozkurt, M. T.
    Cirak, Y.
    Tunali, D.
    Karabulut, B.
    Sanli, U. A.
    Uslu, R.
    MEDICAL ONCOLOGY, 2010, 27 (03) : 585 - 591
  • [35] Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma
    She, Lei
    Su, Lin
    Shen, Liangfang
    Liu, Chao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] A PHARMACOKINETIC AND PHARMACOGENETIC STUDY OF ALISERTIB COMBINED WITH IRINOTECAN AND TEMOZOLOMIDE IN CHILDREN AND ADOLESCENTS WITH RELAPSED OR REFRACTORY NEUROBLASTOMA.
    Kudgus, R. A.
    Fox, E.
    McGovern, R. M.
    Moorthy, G.
    Marachelian, A.
    DuBois, S. G.
    Reid, J. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S68 - S68
  • [37] Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety
    Tyler Y. Kang
    Tony Jin
    Heinrich Elinzano
    David Peereboom
    Journal of Neuro-Oncology, 2008, 89
  • [38] Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety
    Kang, Tyler Y.
    Jin, Tony
    Elinzano, Heinrich
    Peereboom, David
    JOURNAL OF NEURO-ONCOLOGY, 2008, 89 (01) : 113 - 118
  • [39] Phase I study of oral irinotecan, temozolomide, and vincristine for children with refractory solid tumors: A Children's Oncology Group study
    Perentesis, J. P.
    Wagner, L. M.
    Ames, M. M.
    Reid, J. M.
    Stewart, C. F.
    Ingle, A. M.
    Blaney, S. M.
    Adamson, P. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study
    Shujie Zhou
    Fei Ren
    Chaozhuo Li
    Liyang Jiang
    Xiangjiao Meng
    Zhaoqin Huang
    Journal of Neuro-Oncology, 2022, 160 : 631 - 642
12345